Peptides8 min read
Lente or NPH insulin for a diabetic dog?
A randomized dog study supports two insulin options, while current guidance explains why the individual response and matching device still matter.
Read articleBlog
Research, explained. Explore peptides, supplements and hormone health with clear, practical breakdowns of what the studies actually tell us.
Peptides articles
All articlesMetabolism, recovery and emerging research
Peptides9 min read
Insulin research in feline ketoacidosis: hospital evidence, not a home protocol
A small randomized trial supports studying different hospital insulin regimens for feline ketoacidosis. Its findings depend on intensive monitoring and cannot be reduced to a home injection schedule.
Read article
Peptides9 min read
Does GLP-1 weight loss mean muscle loss? Read the measurement first
Lean mass, skeletal muscle and strength are different measurements. Read the semaglutide and tirzepatide studies without turning scan results into muscle diagnoses.
Read article
Peptides8 min read
Pigmentation isn't proof of protection from skin cancer
Afamelanotide can change pigmentation and short-term UV responses. Those findings do not establish that tanning peptides prevent skin cancer.
Read article
Peptides9 min read
CagriSema and REDEFINE 1: why one trial has two weight-loss numbers
Why REDEFINE 1 reports 20.4% and 22.7% weight reduction, what each analysis includes, and how dose flexibility changes the interpretation.
Read article
Peptides9 min read
Pemvidutide and MASH: what the IMPACT liver biopsies showed
IMPACT showed a MASH-resolution signal at 24 weeks, while its primary fibrosis comparison remained inconclusive. Later tests answer different questions.
Read article
Peptides8 min read
Retatrutide and sensitive skin: how trials describe dysesthesia
Retatrutide trials report unpleasant skin sensations, but a symptom label is not a diagnosis of nerve damage. Here is what the data and terminology mean.
Read article
Peptides9 min read
The case for following amylin drugs beyond the GLP-1 headlines
Amylin research offers a distinct biological approach and several clinical strategies. The evidence depends on the exact drug, combination and population.
Read article
Peptides9 min read
Petrelintide tolerability: what the trials actually show
Early petrelintide studies reported mostly mild symptoms. The larger phase 2 publication adds a more detailed, and more qualified, safety picture.
Read article
Peptides9 min read
Zenagamtide tablets and injections: what changes with the formulation?
Zenagamtide has real tablet and injection programs. Their absorption, diabetes results and longer obesity studies answer different questions.
Read article
Peptides9 min read
PT-141 approval: who bremelanotide is actually for
What acquired, generalized HSDD means, who was studied, and why bremelanotide approval does not extend to every sexual-health claim.
Read article
Peptides8 min read
PT-141 and blood pressure: why a temporary rise matters
Bremelanotide's pressure effect can be brief yet clinically relevant. Understand its timing, ambulatory measurements, contraindications and practical monitoring.
Read article25–36 of 320 articles